There is much uncertainty for the company’s minority shareholders amid substantial shareholder dispute, possible lawsuits
CORDLIFE Group has been granted a reprieve, following the Ministry of Health’s (MOH) notice on Aug 29 that it could resume some cord-blood banking services in a “controlled manner” from Sep 15.
Although this signals that things could be getting back on track, some upcoming personnel departures show that the company is not quite out of the woods yet – and investors may need to look for an exit, fast.
The counter has been in dire straits since Cordlife’s Singapore operations were suspended for six months from collecting, processing, testing or storing new cord-blood units in December last year.
